Radiation to Treat Multiple Myeloma

An i3+3 Phase I Hypofractionation Trial for Multiple Myeloma

What's the purpose of the trial?

Doctors leading this study would like to see if a shorter radiation course (i.e., hypofractionation) for pelvic radiation is safe for multiple myeloma.

Trial status

Accepting patients

Phase
Phase 1
Enrollment
30
Last Updated
1 week ago
Patient Screener

Participating Centers

There is one center participating in this trial. Enter a location below to view the distance.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • Radiation therapy uses high doses of radiation to help target and kill many different kinds of cancer throughout the body.

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Accepting patients

Group 1 - Dose Schedule 1

Accepting patients

Group 2 - Dose Schedule 2

Accepting patients

Group 3 - Dose Schedule 3

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.